Doranne Frano

Doranne Frano is a seasoned professional with extensive experience in regulatory affairs and quality assurance in the pharmaceutical and biotechnology sectors. As the Vice President of Regulatory and Quality Assurance at Intensity Therapeutics, Inc. since February 2024, Doranne brings a wealth of expertise gained from leadership roles at notable companies including Liberty Consulting, where Doranne has served as CEO since June 1995, and as Vice President of Regulatory Affairs at HUYA Bioscience International and La Jolla Pharmaceutical Company. Additional roles include senior leadership positions at Profounda, Ambit Biosciences, WomanCare Global, BioVascular Inc., and ACADIA Pharmaceuticals. Doranne holds a Master of Business Administration from Roosevelt University and a Master of Science in Pharmaceutical Sciences from Temple University.